Immatics (IMTX) Current Leases (2019 - 2025)
Immatics (IMTX) posted Current Leases of $3.2 million for Q4 2025, down 5.62% sequentially from $3.4 million in Q2 2025, and up 5.34% YoY from $3.0 million in Q4 2024.
Immatics (IMTX) Current Leases (2019 - 2025) Analysis & Trends
Immatics has reported Current Leases for 7 years, with the latest figure at $3.2 million in Q4 2025.
- Quarterly Current Leases rose 5.34% year-over-year to $3.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 million (up 5.34% YoY) and the FY2025 annual result came in at $3.1 million, up 0.94% from the prior year.
- Current Leases slipped to $3.2 million in Q4 2025 per IMTX's latest filing, from $3.4 million in the prior quarter.
- Over five years, Current Leases peaked at $3.4 million in Q2 2024 and troughed at $2.2 million in Q4 2022.
- A 5-year average of $3.0 million and a median of $3.0 million in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2021 and 2022: Current Leases jumped 38.28% in 2021, then fell 28.97% in 2022.
- Over 5 years, Current Leases stood at $3.1 million in 2021, then decreased by 28.97% to $2.2 million in 2022, then grew by 27.2% to $2.8 million in 2023, then climbed by 8.74% to $3.0 million in 2024, then rose by 5.34% to $3.2 million in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $3.2 million, $3.4 million, and $3.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | 3.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.21 Mn |
| Jun 30, 2025 | 3.40 Mn |
| Dec 31, 2024 | 3.05 Mn |
| Jun 30, 2024 | 3.42 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Jun 30, 2023 | 2.98 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Jun 30, 2022 | 2.59 Mn |
| Dec 31, 2021 | 3.10 Mn |
| Jun 30, 2021 | 2.80 Mn |
| Dec 31, 2020 | 2.24 Mn |
| Dec 31, 2019 | 1.56 Mn |